Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H22NOS2.Br.H2O |
Molecular Weight | 418.412 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.[Br-].COC1CC(C[N+](C)(C)C1)=C(C2=CC=CS2)C3=CC=CS3
InChI
InChIKey=LESIBJVNNLJUOA-UHFFFAOYSA-M
InChI=1S/C17H22NOS2.BrH.H2O/c1-18(2)11-13(10-14(12-18)19-3)17(15-6-4-8-20-15)16-7-5-9-21-16;;/h4-9,14H,10-12H2,1-3H3;1H;1H2/q+1;;/p-1
Molecular Formula | BrH |
Molecular Weight | 80.912 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | HO |
Molecular Weight | 17.0073 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C17H22NOS2 |
Molecular Weight | 320.493 |
Charge | 1 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
CNS Activity
Sources: https://en.wikipedia.org/wiki/Timepidium_bromide
Curator's Comment: Timepidium does not cross the blood–brain barrier
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL216 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10374898 |
34.0 nM [Ki] | ||
Target ID: CHEMBL211 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10374898 |
7.7 nM [Ki] | ||
Target ID: CHEMBL245 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10374898 |
31.0 nM [Ki] | ||
Target ID: CHEMBL1821 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10374898 |
18.0 nM [Ki] | ||
Target ID: CHEMBL2035 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10374898 |
11.0 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Sesden Approved UseVisceral spasms |
PubMed
Title | Date | PubMed |
---|---|---|
Eosinophilic pustular folliculitis induced by allopurinol and timepidium bromide. | 2002 |
|
Multiple granulomatous inflammation in the minor salivary glands: a proposed new entity, allergic granulomatous sialadenitis. | 2004 Nov |
|
Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. | 2010 Dec |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7452982
Timepidium inhibited dose-dependently
the contraction of isolated guinea pig gallbladder evoked by stimulation at 5 Hz. The mean dose producing a 50 % decrease
in the electrically induced contraction (ID50 value) was 2.4 x 10(-8) g/ml. Timepidium (10(-6) g/ml)
also inhibited, for the most part, the contraction induced by stimulation at 30 Hz.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 07:15:24 UTC 2023
by
admin
on
Sat Dec 16 07:15:24 UTC 2023
|
Record UNII |
5X58HSG8LX
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
11954250
Created by
admin on Sat Dec 16 07:15:24 UTC 2023 , Edited by admin on Sat Dec 16 07:15:24 UTC 2023
|
PRIMARY | |||
|
5X58HSG8LX
Created by
admin on Sat Dec 16 07:15:24 UTC 2023 , Edited by admin on Sat Dec 16 07:15:24 UTC 2023
|
PRIMARY | |||
|
116383-38-1
Created by
admin on Sat Dec 16 07:15:24 UTC 2023 , Edited by admin on Sat Dec 16 07:15:24 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ANHYDROUS->SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |